Results 1 to 10 of about 33,608 (178)

Yellow Fever outbreaks in unvaccinated populations, Brazil, 2008-2009.

PLoS Neglected Tropical Diseases, 2014
Due to the risk of severe vaccine-associated adverse events, yellow fever vaccination in Brazil is only recommended in areas considered at risk for disease.
Alessandro Pecego Martins Romano, Zouraide Guerra Antunes Costa, Daniel Garkauskas Ramos, Maria Auxiliadora Andrade, Valéria de Sá Jayme, Marco Antônio Barreto de Almeida, Kátia Campomar Vettorello, Melissa Mascheretti, Brendan Flannery   +8 more
doaj   +1 more source

Lineage-Specific Real-Time RT-PCR for Yellow Fever Virus Outbreak Surveillance, Brazil

Emerging Infectious Diseases, 2017
The current yellow fever outbreak in Brazil prompted widespread yellow fever virus (YFV) vaccination campaigns, imposing a responsibility to distinguish between vaccine- and wild-type YFV-associated disease. We developed novel multiplex real-time reverse
Carlo Fischer, Maria C. Torres, Pranav Patel, Andres Moreira-Soto, Ernest A. Gould, Rémi N. Charrel, Xavier de Lamballerie, Rita Maria Ribeiro Nogueira, Patricia C. Sequeira, Cintia D.S. Rodrigues, Beate M. Kümmerer, Christian Drosten, Olfert Landt, Ana Maria Bispo de Filippis, Jan Felix Drexler   +14 more
doaj   +1 more source

Descriptive Characterization of Suspected Yellow Fever Cases in Kano state, Nigeria, 2015-2018

Journal of Interventional Epidemiology and Public Health, 2021
Introduction: Yellow fever remains a serious public health problem globally with an estimated 200, 000 cases annually despite the availability of an effective vaccine for more than 70 years. Nigeria had an outbreak of Yellow fever in 2017 after more than
Usman Yahya Umar, Kabiru Sabitu, Shehu Sani Mohammed, Nura Yahya Karaye, Muhammad Shakir Balogun   +4 more
doaj   +1 more source

Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group

Acta Médica Portuguesa, 2018
Introduction: Yellow fever is a vector-borne disease in sub-Saharan Africa and tropical South America regions which is preventable by an effective and safe vaccine.
Clarisse Martinho, David Lopes, Luciana Bastos, Hugo Esteves   +3 more
doaj   +1 more source

Changing epidemiology of yellow fever virus in Oyo State, Nigeria

BMC Public Health, 2022
Background Yellow Fever is an acute viral hemorrhagic disease endemic in tropical Africa and Latin America and is transmitted through infected mosquitoes.
Bassey Enya Bassey, Fiona Braka, Rosemary Onyibe, Olufunmilola Olawumi Kolude, Marcus Oluwadare, Alawale Oluwabukola, Ogunlaja Omotunde, Oluwatobi Adeoluwa Iyanda, Adedamola Ayodeji Tella, Olayiwola Suliat Olanike   +9 more
doaj   +1 more source

Travel pattern and profile of clients using online registration system and mobile accessibility for vaccination in a newly established yellow fever vaccination clinic at AIIMS Patna, India

Indian Journal of Community and Family Medicine, 2017
Background: Prevention of Yellow Fever (YF) in travellers to Yellow Fever endemic zone can be done with YF 17D vaccine which is a live attenuated vaccine and can be given only up to one hour after reconstitution.
Dhananjay Kumar, Pragya Kumar, Neeraj Agarwal, Chandra Mani Singh, Sanjay Pandey, Alok Ranjan   +5 more
doaj   +1 more source

Yellow fever vaccine

BMJ, 2002
Three recently published articles, from Brazil, the United States, and Australia, and three follow up letters from Europe, have challenged the reputation of the yellow fever vaccine, 17D, that for more than 50 years was almost beyond reproach.1–6 These reports describe an illness resembling yellow fever occurring within a week of vaccination for yellow
openaire   +3 more sources

The obscurance of the greatest sylvatic yellow fever epidemic and the cooperation of the Pan American Health Organization during the COVID-19 pandemic

Revista da Sociedade Brasileira de Medicina Tropical, 2020
INTRODUCTION: Since 2016, Brazil has been in the midst of its largest sylvatic yellow fever epidemic ever, found predominantly outside the Amazon region.
Carlos Frederico Campelo de Albuquerque e Melo, Pedro Fernando da Costa Vasconcelos, Luiz Carlos Júnior Alcantara, Wildo Navegantes de Araujo   +3 more
doaj   +1 more source

Neurologic Disease after Yellow Fever Vaccination, São Paulo, Brazil, 2017–2018

Emerging Infectious Diseases, 2021
Yellow fever (YF) vaccine can cause neurologic complications. We examined YF vaccine–associated neurologic disease reported from 3 tertiary referral centers in São Paulo, Brazil, during 2017–2018 and compared the performance of criteria established by ...
Ana Freitas Ribeiro, Bruno Fukelmann Guedes, Jamal M.A.H. Sulleiman, Francisco Tomaz Meneses de Oliveira, Izabel Oliva Marcilio de Souza, Juliana Silva Nogueira, Rosa Maria Nascimento Marcusso, Eder Gatti Fernandes, Guilherme Sciascia do Olival, Pedro Henrique Fonseca Moreira de Figueiredo, Ana Paula Rocha Veiga, Flávia Esper Dahy, Natália Nasser Ximenes, Lecio Figueira Pinto, José Ernesto Vidal, Augusto Cesar Penalva de Oliveira   +15 more
doaj   +1 more source

ZNF33B Promotes Japanese Encephalitis Virus Infection by Regulating the Stability of M6A‐Modified Trim25 to Control the Autophagy Process

Advanced Science, EarlyView.
Upon JEV infection, ZNF33B recruits METTL14 to stabilize the METTL3‐METTL14 m6A methyltransferase complex, leading to increased m6A modification of host transcripts, including Trim25 mRNA. ZNF33B selectively binds m6A‐modified sites on Trim25 mRNA and accelerates its decay, resulting in reduced TRIM25 protein abundance.
Jian Du, Chunwei Li, Jiyuan Luo, Huizhi Zhang, Jinyan Zhang, Suya Wang, Huanchun Chen, Hongli Xu, Xiangmin Li, Ping Qian   +9 more
wiley   +1 more source